Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -10.06 is 71% above its 5-year average of -34.56, near the high end of its 5-year range (-82.20–-10.06).
27.26% above its 12-month average of -13.83.
Reported quarterly EPS; no daily interpolation. Q1 FY2027 (2026-06-30): -1.19.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-10.06
EARNINGS PER SHARE (EPS) AVG TTM
-13.83
EARNINGS PER SHARE (EPS) AVG 3Y
-22.37
EARNINGS PER SHARE (EPS) AVG 5Y
-34.56
EARNINGS PER SHARE (EPS) AVG 10Y
-23.39
EARNINGS PER SHARE (EPS) AVG 15Y
-12.16
EARNINGS PER SHARE (EPS) AVG 20Y
-7.73
CURRENT VS TTM AVG
+27.26%
CURRENT VS 3Y AVG
+55.02%
CURRENT VS 5Y AVG
+70.89%
CURRENT VS 10Y AVG
+57.00%
CURRENT VS 15Y AVG
+17.28%
CURRENT VS 20Y AVG
-30.11%
Modular Medical, Inc.
Market Cap
$21.03M
Earnings Per Share (EPS)
-10.06
TTM Avg
-13.83
3Y Avg
-22.37
5Y Avg
-34.56
Market Cap
$21.93M
Earnings Per Share (EPS)
-32.78
TTM Avg
-24.95
3Y Avg
-26.53
5Y Avg
-21.18
Market Cap
$19.54M
Earnings Per Share (EPS)
-0.89
TTM Avg
-2.16
3Y Avg
-1.83
5Y Avg
-1.83
Market Cap
$22.22M
Earnings Per Share (EPS)
-1.66
TTM Avg
-1.66
3Y Avg
-2.82
5Y Avg
-25.82
Market Cap
$19.72M
Earnings Per Share (EPS)
-32.95
TTM Avg
-46.02
3Y Avg
-111.83
5Y Avg
-112.54
Market Cap
$19.20M
Earnings Per Share (EPS)
-0.25
TTM Avg
-0.29
3Y Avg
-0.28
5Y Avg
-0.20
Market Cap
$18.73M
Earnings Per Share (EPS)
-7.26
TTM Avg
-1.65
3Y Avg
-0.89
5Y Avg
-0.63
Market Cap
$18.67M
Earnings Per Share (EPS)
-10.58
TTM Avg
-21.77
3Y Avg
-25.72
5Y Avg
-24.83
Market Cap
$24.23M
Earnings Per Share (EPS)
N/A
TTM Avg
22.45
3Y Avg
9.70
5Y Avg
5.59
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Modular Medical, Inc. (MODD) | $21.03M | -10.06 | -13.83 | -22.37 | -34.56 |
| LeonaBio, Inc. (LONA)vs › | $21.93M | -32.78 | -24.95 | -26.53 | -21.18 |
| Actuate Therapeutics Inc (ACTU)vs › | $19.54M | -0.89 | -2.16 | -1.83 | -1.83 |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.22M | -1.66 | -1.66 | -2.82 | -25.82 |
| P3 Health Partners Inc. (PIII)vs › | $19.72M | -32.95 | -46.02 | -111.83 | -112.54 |
| Estrella Immunopharma, Inc. (ESLA)vs › | $19.20M | -0.25 | -0.29 | -0.28 | -0.20 |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.73M | -7.26 | -1.65 | -0.89 | -0.63 |
| NextCure, Inc. (NXTC)vs › | $18.67M | -10.58 | -21.77 | -25.72 | -24.83 |
| Kyntra Bio, Inc. (KYNB)vs › | $24.23M | N/A | 22.45 | 9.70 | 5.59 |
| Atossa Therapeutics, Inc. (ATOS)vs › | $25.19M | -4.34 | -3.52 | -3.45 | -7.67 |
Trailing EPS (TTM)
$-10.06
Forward EPS (Est.)
$-17.10
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2026-03-31 | -12.36 |
| 2025-03-31 | -15.30 |
| 2024-03-31 | -23.40 |
| 2023-03-31 | -38.40 |
| 2022-03-31 | -82.20 |
| 2021-03-31 | -35.70 |
| 2020-03-31 | -26.70 |
| 2019-03-31 | -13.80 |
| 2018-03-31 | -4.50 |
| 2017-06-30 | -2.74 |
| 2016-06-30 | -2.24 |
| 2015-06-30 | -2.23 |
| 2014-06-30 | -1.64 |
| 2013-06-30 | -1.50 |
| 2012-06-30 | -1.26 |
| 2011-06-30 | -0.66 |
| 2010-06-30 | -0.55 |
| 2009-06-30 | -0.68 |
| 2008-06-30 | -0.48 |
| 2007-06-30 | -0.47 |
| 2006-06-30 | -0.70 |
| 2005-06-30 | -1.80 |
| 2004-06-30 | -1.42 |
